Your browser doesn't support javascript.
loading
The effect of arabinoxylooligosaccharides on upper gastroduodenal motility and hunger ratings in humans.
Scarpellini, E; Deloose, E; Vos, R; Francois, I; Delcour, J A; Broekaert, W F; Verbeke, K; Tack, J.
Affiliation
  • Scarpellini E; Division of Gastroenterology, Department of Internal Medicine, TARGID, University Hospital Gasthuisberg, Leuven, Belgium.
  • Deloose E; Division of Gastroenterology, Department of Internal Medicine, TARGID, University Hospital Gasthuisberg, Leuven, Belgium.
  • Vos R; Division of Gastroenterology, Department of Internal Medicine, TARGID, University Hospital Gasthuisberg, Leuven, Belgium.
  • Francois I; Laboratory of Food Chemistry and Biochemistry & Leuven Food Science and Nutrition Research Centre (LFoRCe), Catholic University of Leuven, Leuven, Belgium.
  • Delcour JA; FUGEIA NV, Arenberg Science Park, Leuven, Belgium.
  • Broekaert WF; FUGEIA NV, Arenberg Science Park, Leuven, Belgium.
  • Verbeke K; Division of Gastroenterology, Department of Internal Medicine, TARGID, University Hospital Gasthuisberg, Leuven, Belgium.
  • Tack J; Division of Gastroenterology, Department of Internal Medicine, TARGID, University Hospital Gasthuisberg, Leuven, Belgium.
Neurogastroenterol Motil ; 30(7): e13306, 2018 07.
Article in En | MEDLINE | ID: mdl-29436142
ABSTRACT
BACKGROUND AND

AIMS:

Prebiotics such as Arabinoxylooligosaccharides (AXOS) are non-digestible, fermentable food ingredients stimulating growth/activity of colonic bacteria with enhanced carbohydrates fermentation (CF) in humans. The migrating motor complex (MMC) of the gastrointestinal tract has been recently identified as an important hunger signal, but no data are available yet on the role of acute CF on MMC activity and related hunger ratings. Thus, we aimed to study the effect of acute AXOS CF on MMC and hunger in humans.

METHODS:

A total of 13 healthy volunteers were randomized in a single-blind crossover placebo-controlled study where 9.4 g of AXOS or 10 g of maltodextrin and 1 g of unlabelled lactose ureide (LU) were given 12 hours prior to the study and, in the next morning, together with a pancake containing 500 mg of 13 C-LU. In 10 hours after the meal, 13 CO2 and hydrogen excretion were determined every 15 minutes while hunger/appetite ratings every 2 minutes through a VAS questionnaire. Five hours after the meal, antroduodenal motility was measured using HRM. KEY

RESULTS:

AXOS significantly increased CF (158 ± 81 vs 840 ± 464 H2 ppm*minute, placebo vs AXOS, P < .05) without affecting the orocecal transit time (OCTT). AXOS had no significant effect on the occurrence, origin, and duration of phase III and on the total number, origin, and duration of phases I and II. Hunger and appetite scores prior and after phase III were not affected by AXOS.

CONCLUSIONS:

AXOS acutely increases colonic fermentation, but this neither affects OCTT, activity of the MMC, nor interdigestive hunger scores in man.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligosaccharides / Hunger / Duodenum / Prebiotics / Gastrointestinal Motility Type of study: Clinical_trials / Prognostic_studies Aspects: Determinantes_sociais_saude Limits: Adult / Female / Humans / Male Language: En Journal: Neurogastroenterol Motil Journal subject: GASTROENTEROLOGIA / NEUROLOGIA Year: 2018 Document type: Article Affiliation country: Belgium

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligosaccharides / Hunger / Duodenum / Prebiotics / Gastrointestinal Motility Type of study: Clinical_trials / Prognostic_studies Aspects: Determinantes_sociais_saude Limits: Adult / Female / Humans / Male Language: En Journal: Neurogastroenterol Motil Journal subject: GASTROENTEROLOGIA / NEUROLOGIA Year: 2018 Document type: Article Affiliation country: Belgium